Loading...
Loading...
Charming Medical Ltd
Charming Medical Ltd. Spoken Alpha tracks MCTA's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks MCTA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MCTA.
curl https://api.spokenalpha.com/v1/companies/MCTA| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.85 | $3.32 | +46.0% | +2.6% | +2.2% |
| Q4 FY2026 | $4.70 | $3.14 | +49.7% | +9.6% | +9.5% |
| Q3 FY2026 | $4.62 | $3.40 | +35.8% | +1.3% | +0.7% |
| Q2 FY2026 | $4.90 | $3.30 | +48.5% | -1.1% | +1.7% |
| Q1 FY2025 | $4.94 | $3.43 | +44.1% | +8.9% | +7.7% |
| Q4 FY2025 | $4.88 | $3.45 | +41.5% | +9.6% | +7.7% |
| Q3 FY2025 | $5.19 | $3.47 | +49.6% | -0.4% | +2.2% |
| Q2 FY2025 | $4.88 | $3.36 | +45.1% | +0.8% | +0.4% |
| Q1 FY2024 | $4.90 | $3.34 | +46.7% | -1.1% | +1.2% |
| Q4 FY2024 | $4.76 | $3.29 | +44.8% | +1.2% | +0.2% |